Biotech: Pressemitteilungen - Kategorie - Seite 190

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Sarepta Therapeutics Announces Second Quarter 2012 Financial Results and Corporate Update Conference Call

CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 07/31/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, will report second quarter 2012 financial results after the N ...

Quick-Med Technologies Appoints Bernd Liesenfeld as President

GAINESVILLE, FL: Roy Carr Promoted to Vice President of Business Development and William Toreki to Vice President of Research & Development as Part of Management Transition ...

La Jolla Pharmaceutical Company Announces FDA Agreement With Proposed Phase 1 Clinical Trial of GCS-100 in Chronic Kidney Disease

SAN DIEGO, CA: SAN DIEGO, CA -- (Marketwire) -- 07/31/12 -- (OTCQB: LJPC) (PINKSHEETS: LJPC), a leader in the development of therapeutics that target , announced today that the FDA Division of Cardiovascular and R ...

Immunovative, Inc. Announces the Retention of Winston & Strawn LLP as Its Legal Counsel

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 07/31/12 -- Immunovative, Inc. ("IMUN") (OTCBB: IMUN) announced today that the company has retained the law firm of Winston & Strawn LLP as its primary o ...

Functional Technologies Reports Third Quarter 2012 Financial Results

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 07/30/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") today reported operational and financial results for the third q ...

Bradmer Announces Second Quarter Operational and Financial Results

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwire) -- 07/30/12 -- Bradmer Pharmaceuticals Inc. (TSX VENTURE: BMR.H) ("Bradmer" or the "Company") today announced its second quarter 2012 operational ...

Peregrine Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement

TUSTIN, CA: TUSTIN, CA -- (Marketwire) -- 07/30/12 -- Peregrine Pharmaceuticals (NASDAQ: PPHM) today announced that it has received a letter from The NASDAQ Stock Market LLC notifying the company that it has reg ...

Immunovative, Inc. Announces Launch of Website and Newsletter: ImmuNews

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 07/30/12 -- Immunovative, Inc. ("IMUN") (OTCBB: IMUN) announced today that the company has launched a new website that includes information on our technolog ...

Aeolus Pharmaceuticals Announces AEOL 10150 Diminishes Oxidative Stress and Nerve Damage Following Exposure to Nerve Agent

MISSION VIEJO, CA: MISSION VIEJO, CA -- (Marketwire) -- 07/30/12 -- Aeolus Pharmaceuticals, Inc. (OTCQB: AOLS) (OTCBB: AOLS), a biotechnology company leveraging significant government funding to develop a platform of n ...

Despite Facing Patent Expirations Major Pharmaceuticals Performing Admirably in 2012

NEW YORK, NY: The Paragon Report Provides Stock Research on Pfizer and Johnson & Johnson ...

Horizon Pharma to Host Conference Call and Webcast to Discuss Second Quarter 2012 Financial Results on August 10, 2012

DEERFIELD, IL: DEERFIELD, IL -- (Marketwire) -- 07/30/12 -- Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its second quarter 2012 financial results will be released on Friday, August 10, 2012. Following ...

HTG Molecular Diagnostics Achieves ISO 13485:2003 Certification

TUCSON, AZ: Demonstrating Internationally Recognized Standards for Quality Management in Provision of Medical Devices and Related Services ...

ProMetic Life Sciences and NantPharma, a NantWorks Company, to Develop and Commercialize Plasma-Derived Biopharmaceuticals

LOS ANGELES, USA and LAVAL, QUEBEC, CANADA: - ProMetic receives an initial US $2.5 Million from NantPharma - ProMetic to be exclusive development partner - ProMetic to manufacture bulk active at its Laval facility - ProMetic to retain rights to ...

Agennix AG Announces Notice of Allowance for U.S. Patent Application Covering Use of Talactoferrin Alfa to Treat Non-Small Cell Lung Cancer and Renal Cancer in Combination With Other Treatments

PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX: PLANEGG, GERMANY and MUNICH, GERMANY and PRINCETON, NJ and HOUSTON, TX -- (Marketwire) -- 07/30/12 -- Agennix AG (FRANKFURT: AGX) (XETRA: AGX) today announced that the U.S. Patent and Trademark Offic ...

Prima BioMed to Release Interim CVac Clinical Data

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwire) -- 07/29/12 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) (Prima, the Company) announces that it will be releasing interim results from its CVac™ clinical trial CA ...

Sarepta Therapeutics Regains NASDAQ Compliance

CAMBRIDGE, MA: CAMBRIDGE, MA -- (Marketwire) -- 07/27/12 -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that it received a letter from the listing qu ...

Immunovative, Inc. Announces Formation of a Business Advisory Board and the Appointment of Bruno Vanderschelden as Chairman

NEW YORK, NY: NEW YORK, NY -- (Marketwire) -- 07/27/12 -- Immunovative, Inc. ("IMUN") (OTCBB: IMUN) announces today the formation of a Business Advisory Board and the appointment of Bruno Vanderschelden ...

Harper Government Teams With Canadian Researchers to Bolster Food Safety System

OTTAWA, ONTARIO: OTTAWA, ONTARIO -- (Marketwire) -- 07/26/12 -- The Canadian Food Inspection Agency, Genome Canada and Alberta Innovates Bio Solutions are partnering in a $600,000 project that will help protect cons ...


Seite 190 von 255:  « ..  189 190 191  192  193  194  195  196  197  198  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z